In vivo estrogenic comparisons of Trifolium pratense (red clover) Humulus lupulus (hops), and the pure compounds isoxanthohumol and 8-prenylnaringenin

Chemico-Biological Interactions

Volumn 176, Issue 1, 2008, Pages 30-39

  Overk, Cassia R ^a   Guo, Jian ^a   Chadwick, Lucas R ^b   Lantvit, Daniel D ^a   Minassi, Alberto ^c   Appendino, Giovanni ^c   Chen, Shao Nong ^a   Lankin, David C ^a   Farnsworth, Norman R ^a   Pauli, Guido F ^a   van Breemen, Richard B ^a   Bolton, Judy L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Kalsec Inc   (United States)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

8 Prenylnaringenin; Estrogen; Humulus lupulus; Isoxanthohumol; Menopause; Trifolium pratense

Indexed keywords

8 PRENYLNARINGENIN; HUMULUS LUPULUS EXTRACT; ISOXANTHOHUMOL; RED CLOVER EXTRACT; UNCLASSIFIED DRUG; XANTHOHUMOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG METABOLISM; DRUG TISSUE LEVEL; ESTROGEN ACTIVITY; FEMALE; HUMULUS LUPULUS; IN VIVO STUDY; LIVER; MAMMARY GLAND; NONHUMAN; ORGAN WEIGHT; RAT; RED CLOVER; UTERUS; WEIGHT GAIN;

ANIMALS; BODY WEIGHT; CHROMATOGRAPHY, LIQUID; EOSINE YELLOWISH-(YS); EPITHELIAL CELLS; ESTROGENS; FEMALE; FLAVANONES; HEMATOXYLIN; HUMULUS; MASS SPECTROMETRY; ORGAN SIZE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; TRIFOLIUM; UTERUS; XANTHONES;

HUMULUS; HUMULUS LUPULUS; RATTUS; TRIFOLIUM PRATENSE;

EID: 53149105189     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.06.005     Document Type: Article

References (45)

1. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A., Howard B.V., Johnson K.C., Kotchen J.M., and Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J. Am. Med. Assoc. 288 (2002) 321-333
2. Haas J.S., Kaplan C.P., Gerstenberger E.P., and Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann. Intern. Med. 140 (2004) 184-188
3. Murkies A.L., Wilcox G., and Davis S.R. Clinical review 92: Phytoestrogens. Clin. Endocrinol. Metab. 83 (1998) 297-303
4. Setchell K.D. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am. J. Clin. Nutr. 68 (1998) 1333S-1346S
5. Setchell K.D., and Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J. Nutr. 129 (1999) 758S-767S
6. Anonymous, What are bioidentical hormones, Harvard Women's Health Watch 13 (2006) 1-3.
7. Calixto J.B. Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents). Braz. J. Med. Biol. Res. 33 (2000) 179-189
8. Liu J., Burdette J.E., Xu H., Gu C., van Breemen R.B., Bhat K.P., Booth N., Constantinou A.I., Pezzuto J.M., Fong H.H., Farnsworth N.R., and Bolton J.L. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J. Agric. Food Chem. 49 (2001) 2472-2479
9. Liggins J., Bluck L.J., Coward W.A., and Bingham S.A. Extraction and quantification of daidzein and genistein in food. Anal. Biochem. 264 (1998) 1-7
10. Piersen C.E., Booth N.L., Sun Y., Liang W., Burdette J.E., van Breemen R.B., Geller S.E., Gu C., Banuvar S., Shulman L.P., Bolton J.L., and Farnsworth N.R. Chemical and biological characterization and clinical evaluation of botanical dietary supplements: a phase I red clover extract as a model. Curr. Med. Chem. 11 (2004) 1361-1374
11. Hu M., Krausz K., Chen J., Ge X., Li J., Gelboin H.L., and Gonzalez F.J. Identification of CYP1A2 as the main isoform for the phase I hydroxylated metabolism of genistein and a prodrug converting enzyme of methylated isoflavones. Drug Metab. Dispos. 31 (2003) 924-931
12. Kronenberg F., and Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann. Intern. Med. 137 (2002) 805-813
13. Piersen C.E. Phytoestrogens in botanical dietary supplements: implications for cancer. Integr. Cancer Ther. 2 (2003) 120-138
14. Stevens J.F., Miranda C.L., Buhler D.R., and Deinzer M.L. Chemistry and biology of hop flavonoids. J. Am. Soc. Brew. Chem. 56 (1998) 136-145
15. Koch W., and Heim G. Estrogens in hops and beer. Munch. Med. Wochenschr. 95 (1953) 845
16. Milligan S.R., Kalita J.C., Heyerick A., Rong H., De Cooman L., and De Keukeleire D. Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. J. Clin. Endocrinol. Metab. 84 (1999) 2249-2252
17. Milligan S.R., Kalita J.C., Pocock V., Van De Kauter V., Stevens J.F., Deinzer M.L., Rong H., and De Keukeleire D. The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. J. Clin. Endocrinol. Metab. 85 (2000) 4912-4915
18. Hänsel R.V., and Schulz J. Desmethylxanthohumol: isolierung aus Hopfen und Cyclisierung zu Flavanonen. Arch. Pharm. Weinheim 321 (1988) 37-40
19. Chadwick L.R., Nikolic D., Burdette J.E., Overk C.R., Bolton J.L., van Breemen R.B., Froehlich R., Fong H.H., Farnsworth N.R., and Pauli G.F. Estrogens and Congeners from Spent Hops (Humulus lupulus L.). J. Nat. Prod. 67 (2004) 2024-2032
20. Milligan S., Kalita J., Pocock V., Heyerick A., De Cooman L., Rong H., and De Keukeleire D. Oestrogenic activity of the hop phyto-oestrogen, 8-prenylnaringenin. Reproduction 123 (2002) 235-242
21. Overk C.R., Yao P., Chadwick L.R., Nikolic D., Sun Y., Cuendet M.A., Deng Y., Hedayat A.S., Pauli G.F., Farnsworth N.R., van Breemen R.B., and Bolton J.L. Comparison of the in vitro estrogenic activities of compounds from hops (Humulus lupulus) and red clover (Trifolium pratense). J. Agric. Food. Chem. 53 (2005) 6246-6253
22. Nikolic D., Li Y., Chadwick L.R., Pauli G.F., and van Breemen R.B. Metabolism of xanthohumol and isoxanthohumol, prenylated flavonoids from hops (Humulus lupulus L.), by human liver microsomes. J. Mass Spectrom. 40 (2005) 289-299
23. Zierau O., Hauswald S., Schwab P., Metz P., and Vollmer G. Two major metabolites of 8-prenylnaringenin are estrogenic in vitro. J. Steroid Biochem. Mol. Biol. 92 (2004) 107-110
24. Nikolic D., Li Y., Chadwick L.R., and van Breemen R.B. In Vitro studies of intestinal permeability and hepatic and intestinal metabolism of 8-prenylnaringenin, a Po ten phytoestrogen from hops (Humulus lupulus L.). Pharm. Res. 23 (2006) 864-872
25. Schaefer, O., Bohlmann, R., Schleuning, W.D., Schulze-Forster, K., M, H. Development of a radioimmunoassay for the quantitative determination of 8-prenylnaringenin in biological matrices. J. Agric. Food Chem. 53 (2005) 2881-2889.
26. Rimoldi G., Christoffel J., and Wuttke W. Morphologic changes induced by oral long-term treatment with 8-prenylnaringenin in the uterus, vagina, and mammary gland of castrated rats. Menopause 13 (2006) 669-677
27. Christoffel J., Rimoldi G., and Wuttke W. Effects of 8-prenylnaringenin on the hypothalamo-pituitary-uterine axis in rats after 3-month treatment. J. Endocrinol. 188 (2006) 397-405
28. Rad M., Humpel M., Schaefer O., Schoemaker R.C., Schleuning W.D., Cohen A.F., and Burggraaf J. Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women. Br. J. Clin. Pharmacol. 62 (2006) 288-296
29. Heyerick A., Vervarcke S., Depypere H., Bracke M., and De Keukeleire D. A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas 54 (2006) 164-175
30. Gester S., Metz P., Zierau O., and Vollmer G. An efficient synthesis of the potent phytoestrogens 8-prenylnaringenin and 6-(1,1-dimethylallyl)naringenin by europium(III)-catalyzed Claisen rearrangement. Tetrahedron 57 (2001) 1015-1018
31. Pauli G.F., Jaki B.U., and Lankin D.C. A Routine experimental protocol for qHNMR illustrated with taxol. J. Nat. Prod. 70 (2007) 589-595
32. Pauli G.F., Jaki B.U., and Lankin D.C. Quantitative 1H NMR: development of and potential of a method for natural products analysis. J. Nat. Prod. 68 (2005) 113-149
33. USFDA, http://www.fda.gov/cber/gdlns/dose.htm#iii (2007).
34. Burdette J.E., Liu J., Lantvit D., Lim E., Booth N., Bhat K.P., Hedayat S., Van Breemen R.B., Constantinou A.I., Pezzuto J.M., Farnsworth N.R., and Bolton J.L. Trifolium pratense (red clover) exhibits estrogenic effects in vivo in ovariectomized Sprague-Dawley rats. J. Nutr. 132 (2002) 27-30
35. Fournier A., Berrino F., Riboli E., Avenel V., and Clavel-Chapelon F. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int. J. Cancer 114 (2005) 448-454
36. Jefferson W.N., Padilla-Banks E., Clark G., and Newbold R.R. Assessing estrogenic activity of phytochemicals using transcriptional activation and immature mouse uterotrophic responses. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 777 (2002) 179-189
37. Owens W., and Koeter H.B. The OECD program to validate the rat uterotrophic bioassay: an overview. Environ. Health Perspect. 111 (2003) 1527-1529
38. Drewett R.F. Oestrous and dioestrous components of the ovarian inhibition on hunger in the rat. Anim. Behav. 21 (1973) 772-780
39. Roesch D.M. Effects of selective estrogen receptor agonists on food intake and body weight gain in rats. Physiol. Behav. 87 (2006) 39-44
40. Bravo L., Cabo J., Fraile A., Jiminez J., and Villar A. Pharmacodynamic study of hops (Humulus lupulus). II. Estrogenic action. Ars. Pharm. 12 (1971) 421-425
41. Kumani A., and Okamoto R. Extraction of the hormonal substance from hop. Toxicol. Lett. 21 (1984) 203-207
42. Okamoto R., and Kumani A. Anitgonadotropic activity of hop extract. Acta Endocrinol. 127 (1992) 371-377
43. Coldham N.G., and Sauer M.J. Identification, quantitation and biological activity of phytoestrogens in a dietary supplement for breast enhancement. Food Chem. Toxicol. 39 (2001) 1211-1224
44. Goetz P. Treatment of hot flashes due to ovarian insufficiency using a hops extract (Humulus lupus). Phytotherapie Pratique 4 (1990) 13-15
45. Bolca S., Possemiers S., Herregat A., Huybrechts I., Heyerick A., De Vriese S., Verbruggen M., Depypere H., De Keukeleire D., Bracke M., De Henauw S., Verstraete W., and Van de Wiele T. Microbial and dietary factors are associated with the equol producer phenotype in healthy postmenopausal women. J. Nutr. 137 (2007) 2242-2246